Skip to main content
Skip to footer

Bayer overhauls it’s clinical trial planning process 

Dr. Subrata Bose

Global Head of Clinical Trials, Analytics and Insights Bayer AG

You have these already downloaded

We have sent you a copy of the report to your email again.

TCS ADD TM is happy to partner with Bayer in its vision to revamp its clinical trial planning process including patient and site recruitment, preparing protocols and conducting planning for trials. We implemented the data driven feasibility solution of TCS ADD Analytics and Insights to generate actionable insights that incorporated real-world data (RWD). In addition, the eSurvey solution mapped to TCS ADD Connected Clinical Trials Platform aided site personnel to remotely and electronically engage in conversation with Bayer representatives and record their response.

Read More
Introducing analytics into the development of study protocols has allowed us data-driven decision making. We already see improvements in study conduct, which will help us to get new medicines to patients faster.
DR.SUBRATA BOSE

Global Head of Clinical Trials, Analytics and Insights Bayer AG

About the author

Dr. Subrata Bose
Using AI and imaging to combat diseases. Leading a global team consisting extremely talented Radiologists,Data Scientists, Program Managers, System Engineers and Problem Solvers to develop applications to detect, monitor and treat life threatening diseases using imaging and AI. Winner of several multimillion pounds AI /imaging research awards from EU, London Development Agency and leading UK University.
Read more about authorRead more about author Read more about author

Related reading

Next-gen clinical trials on a digital platform

Customer Testimonial | 27 Jan 2023

Adopting a Design Thinking Approach for Risk-Based Monitoring

White Paper | 23 Dec 2022

The new age digital contract research organizations

White Paper | 23 Dec 2022

Technology-Driven EDC Platform for Medical Device Trials

White Paper | 23 Dec 2022

Transformation starts here

Learn how we can help you bring drugs to the market faster.

Talk to our experts

Find out more